Mathew NT - Search Results

1

Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL. Mathew NT, et al. Arch Neurol. 1995 Mar;52(3):281-6. doi: 10.1001/archneur.1995.00540270077022. Arch Neurol. 1995. PMID: 7872882 Clinical Trial.

2

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group.

Mathew NT, Dexter J, Couch J, Flamenbaum W, Goldstein J, Rapoport A, Sheftell F, Saper J, Silberstein S, Solomon S, et al. Mathew NT, et al. Arch Neurol. 1992 Dec;49(12):1271-6. doi: 10.1001/archneur.1992.00530360073020. Arch Neurol. 1992. PMID: 1333181 Clinical Trial.

3

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.

Rapoport AM, Ramadan NM, Adelman JU, Mathew NT, Elkind AH, Kudrow DB, Earl NL. Rapoport AM, et al. Among authors: mathew nt. Neurology. 1997 Nov;49(5):1210-8. doi: 10.1212/wnl.49.5.1210. Neurology. 1997. PMID: 9371896 Clinical Trial.

4

Efficacy of gabapentin in migraine prophylaxis.

Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S. Mathew NT, et al. Headache. 2001 Feb;41(2):119-28. doi: 10.1046/j.1526-4610.2001.111006119.x. Headache. 2001. PMID: 11251695 Clinical Trial.

5

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.

Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT. Goldstein DJ, et al. Among authors: mathew nt. Cephalalgia. 1997 Nov;17(7):785-90. doi: 10.1046/j.1468-2982.1997.1707785.x. Cephalalgia. 1997. PMID: 9399010 Clinical Trial.

6

Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.

Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME. Rapoport AM, et al. Among authors: mathew nt. Neurology. 2007 Aug 28;69(9):821-6. doi: 10.1212/01.wnl.0000267886.85210.37. Neurology. 2007. PMID: 17724283 Clinical Trial.

7

Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.

Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, Hirtz D; Chronic Migraine Treatment Trial Research Group. Silberstein SD, et al. Among authors: mathew nt. Neurology. 2012 Mar 27;78(13):976-84. doi: 10.1212/WNL.0b013e31824d5846. Epub 2012 Feb 29. Neurology. 2012. PMID: 22377815 Free PMC article. Clinical Trial.

8

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.

Mathew NT, Asgharnejad M, Peykamian M, Laurenza A. Mathew NT, et al. Neurology. 1997 Dec;49(6):1485-90. doi: 10.1212/wnl.49.6.1485. Neurology. 1997. PMID: 9409334 Clinical Trial.

9

Coexistence of migraine and idiopathic intracranial hypertension without papilledema.

Mathew NT, Ravishankar K, Sanin LC. Mathew NT, et al. Neurology. 1996 May;46(5):1226-30. doi: 10.1212/wnl.46.5.1226. Neurology. 1996. PMID: 8628457

10

Classification of daily and near-daily headaches: proposed revisions to the IHS criteria.

Siberstein SD, Lipton RB, Solomon S, Mathew NT. Siberstein SD, et al. Among authors: mathew nt. Headache. 1994 Jan;34(1):1-7. doi: 10.1111/j.1526-4610.1994.hed3401001.x. Headache. 1994. PMID: 8132434 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page